Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis.

Trouvé P, Génin E, Férec C.

PLoS One. 2017 Mar 24;12(3):e0173822. doi: 10.1371/journal.pone.0173822. eCollection 2017.

2.

Transcriptional Modulator Ifrd1 Regulates Osteoclast Differentiation through Enhancing the NF-κB/NFATc1 Pathway.

Iezaki T, Fukasawa K, Park G, Horie T, Kanayama T, Ozaki K, Onishi Y, Takahata Y, Nakamura Y, Takarada T, Yoneda Y, Nakamura T, Vacher J, Hinoi E.

Mol Cell Biol. 2016 Sep 12;36(19):2451-63. doi: 10.1128/MCB.01075-15. Print 2016 Oct 1.

3.

The C. elegans CCAAT-Enhancer-Binding Protein Gamma Is Required for Surveillance Immunity.

Reddy KC, Dunbar TL, Nargund AM, Haynes CM, Troemel ER.

Cell Rep. 2016 Feb 23;14(7):1581-9. doi: 10.1016/j.celrep.2016.01.055. Epub 2016 Feb 11.

4.

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation.

Tummers B, Goedemans R, Pelascini LP, Jordanova ES, van Esch EM, Meyers C, Melief CJ, Boer JM, van der Burg SH.

Nat Commun. 2015 Mar 13;6:6537. doi: 10.1038/ncomms7537.

5.

Translation of 5' leaders is pervasive in genes resistant to eIF2 repression.

Andreev DE, O'Connor PB, Fahey C, Kenny EM, Terenin IM, Dmitriev SE, Cormican P, Morris DW, Shatsky IN, Baranov PV.

Elife. 2015 Jan 26;4:e03971. doi: 10.7554/eLife.03971.

6.

Tis7 deletion reduces survival and induces intestinal anastomotic inflammation and obstruction in high-fat diet-fed mice with short bowel syndrome.

Garcia AM, Wakeman D, Lu J, Rowley C, Geisman T, Butler C, Bala S, Swietlicki EA, Warner BW, Levin MS, Rubin DC.

Am J Physiol Gastrointest Liver Physiol. 2014 Sep 15;307(6):G642-54. doi: 10.1152/ajpgi.00374.2013. Epub 2014 Jul 24.

7.

Disease-modifying genes and monogenic disorders: experience in cystic fibrosis.

Gallati S.

Appl Clin Genet. 2014 Jul 10;7:133-46. doi: 10.2147/TACG.S18675. eCollection 2014. Review.

8.

Functional and genomic analyses of alpha-solenoid proteins.

Fournier D, Palidwor GA, Shcherbinin S, Szengel A, Schaefer MH, Perez-Iratxeta C, Andrade-Navarro MA.

PLoS One. 2013 Nov 21;8(11):e79894. doi: 10.1371/journal.pone.0079894. eCollection 2013.

9.

CEBPG Exhibits Allele-Specific Expression in Human Bronchial Epithelial Cells.

Blomquist TM, Brown RD, Crawford EL, de la Serna I, Williams K, Yoon Y, Hernandez DA, Willey JC.

Gene Regul Syst Bio. 2013 Jul 4;7:125-38. doi: 10.4137/GRSB.S11879. Print 2013.

10.

Detection and impact of rare regulatory variants in human disease.

Li X, Montgomery SB.

Front Genet. 2013 May 31;4:67. doi: 10.3389/fgene.2013.00067. eCollection 2013.

11.

Genetic influences on cystic fibrosis lung disease severity.

Weiler CA, Drumm ML.

Front Pharmacol. 2013 Apr 23;4:40. doi: 10.3389/fphar.2013.00040. eCollection 2013.

12.

Clinical and molecular characterization of the potential CF disease modifier syntaxin 1A.

von Kanel T, Stanke F, Weber M, Schaller A, Racine J, Kraemer R, Chanson M, Tümmler B, Gallati S.

Eur J Hum Genet. 2013 Dec;21(12):1462-6. doi: 10.1038/ejhg.2013.57. Epub 2013 Apr 10.

13.

Changes in transcriptome of native nasal epithelium expressing F508del-CFTR and intersecting data from comparable studies.

Clarke LA, Sousa L, Barreto C, Amaral MD.

Respir Res. 2013 Mar 28;14:38. doi: 10.1186/1465-9921-14-38.

14.

The influence of genetics on cystic fibrosis phenotypes.

Knowles MR, Drumm M.

Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a009548. doi: 10.1101/cshperspect.a009548.

15.

Identification of SNPs in the cystic fibrosis interactome influencing pulmonary progression in cystic fibrosis.

Gisler FM, von Kanel T, Kraemer R, Schaller A, Gallati S.

Eur J Hum Genet. 2013 Apr;21(4):397-403. doi: 10.1038/ejhg.2012.181. Epub 2012 Aug 15.

16.

Mutations and binding sites of human transcription factors.

Kamanu FK, Medvedeva YA, Schaefer U, Jankovic BR, Archer JA, Bajic VB.

Front Genet. 2012 Jun 1;3:100. doi: 10.3389/fgene.2012.00100. eCollection 2012.

17.

Modifier genes and the plasticity of genetic networks in mice.

Hamilton BA, Yu BD.

PLoS Genet. 2012;8(4):e1002644. doi: 10.1371/journal.pgen.1002644. Epub 2012 Apr 12. Review.

18.

Genetic variation and clinical heterogeneity in cystic fibrosis.

Drumm ML, Ziady AG, Davis PB.

Annu Rev Pathol. 2012;7:267-82. doi: 10.1146/annurev-pathol-011811-120900. Epub 2011 Oct 17. Review.

19.

Modeling human disease in humans: the ciliopathies.

Novarino G, Akizu N, Gleeson JG.

Cell. 2011 Sep 30;147(1):70-9. doi: 10.1016/j.cell.2011.09.014.

20.

Association of common variants in the human eyes shut ortholog (EYS) with statin-induced myopathy: evidence for additional functions of EYS.

Isackson PJ, Ochs-Balcom HM, Ma C, Harley JB, Peltier W, Tarnopolsky M, Sripathi N, Wortmann RL, Simmons Z, Wilson JD, Smith SA, Barboi A, Fine E, Baer A, Baker S, Kaufman K, Cobb B, Kilpatrick JR, Vladutiu GD.

Muscle Nerve. 2011 Oct;44(4):531-8. doi: 10.1002/mus.22115. Epub 2011 Aug 8.

Supplemental Content

Support Center